Mercer Global Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.9M | Buy |
101,092
+11,334
| +13% | +$1.22M | 0.02% | 349 |
|
2025
Q1 | $9.05M | Buy |
89,758
+15,883
| +21% | +$1.6M | 0.02% | 386 |
|
2024
Q4 | $6.6M | Sell |
73,875
-9,459
| -11% | -$845K | 0.02% | 466 |
|
2024
Q3 | $7.01M | Buy |
83,334
+24,365
| +41% | +$2.05M | 0.02% | 411 |
|
2024
Q2 | $4.55M | Buy |
58,969
+888
| +2% | +$68.5K | 0.01% | 477 |
|
2024
Q1 | $3.98M | Buy |
58,081
+9,280
| +19% | +$636K | 0.01% | 526 |
|
2023
Q4 | $2.82M | Buy |
48,801
+955
| +2% | +$55.2K | 0.01% | 629 |
|
2023
Q3 | $2.53M | Buy |
47,846
+15,588
| +48% | +$823K | 0.01% | 628 |
|
2023
Q2 | $1.75M | Buy |
32,258
+4,616
| +17% | +$250K | 0.01% | 769 |
|
2023
Q1 | $1.38M | Sell |
27,642
-1,765
| -6% | -$88.3K | 0.01% | 797 |
|
2022
Q4 | $1.36M | Buy |
29,407
+3,767
| +15% | +$174K | 0.01% | 799 |
|
2022
Q3 | $993K | Buy |
25,640
+751
| +3% | +$29.1K | 0.01% | 845 |
|
2022
Q2 | $927K | Sell |
24,889
-240
| -1% | -$8.94K | 0.01% | 879 |
|
2022
Q1 | $1.11M | Sell |
25,129
-654
| -3% | -$29K | 0.01% | 853 |
|
2021
Q4 | $1.1M | Buy |
25,783
+1,967
| +8% | +$83.5K | 0.01% | 845 |
|
2021
Q3 | $1.03M | Buy |
23,816
+5,569
| +31% | +$242K | 0.01% | 843 |
|
2021
Q2 | $780K | Buy |
18,247
+2,207
| +14% | +$94.3K | 0.01% | 949 |
|
2021
Q1 | $620K | Buy |
16,040
+5,077
| +46% | +$196K | 0.01% | 986 |
|
2020
Q4 | $394K | Sell |
10,963
-472
| -4% | -$17K | ﹤0.01% | 962 |
|
2020
Q3 | $437K | Buy |
11,435
+467
| +4% | +$17.8K | 0.01% | 822 |
|
2020
Q2 | $385K | Sell |
10,968
-181
| -2% | -$6.35K | 0.01% | 770 |
|
2020
Q1 | $364K | Buy |
11,149
+642
| +6% | +$21K | 0.01% | 752 |
|
2019
Q4 | $475K | Sell |
10,507
-229
| -2% | -$10.4K | 0.01% | 752 |
|
2019
Q3 | $436K | Buy |
10,736
+548
| +5% | +$22.3K | 0.01% | 742 |
|
2019
Q2 | $438K | Sell |
10,188
-100
| -1% | -$4.3K | 0.01% | 734 |
|
2019
Q1 | $395K | Buy |
+10,288
| New | +$395K | 0.01% | 723 |
|